Immune checkpoint inhibition in lymphoid disease

E-ISSN： 1365-2141|170|3|291-304

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.3, 2015-08, pp. : 291-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials

Oncology, Vol. 92, Iss. 1, 2017-02 ,pp. : 50-62

Karger

Access to resources Recommend Favorite

Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care

Oncology, Vol. 93, Iss. 3, 2017-06 ,pp. : 164-176

Karger

Access to resources Recommend Favorite

Immune checkpoint inhibitors: new strategies to checkmate cancer

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 191, Iss. 2, 2018-02 ,pp. : 133-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune checkpoint blockade – a treatment for urological cancers?

BJU INTERNATIONAL, Vol. 118, Iss. 4, 2016-10 ,pp. : 498-500

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dual inhibition of Cdc20 by the spindle checkpoint

By Chen Rey-Huei

Journal of Biomedical Science, Vol. 14, Iss. 4, 2007-07 ,pp. : 475-479

Springer Publishing Company

Access to resources Recommend Favorite